PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
15-Feb-2024 Kyriba’s Quarterly Currency Impact Report: Currency Impact Reported by North American and European Companies Totaled $30 Billion Businesswire
15-Feb-2024 Firefly Bio Debuts With $94 Million Series A Financing Businesswire
15-Feb-2024 Selkirk Pharma Announces New APS Qualified Facility with Advanced Fill/Finish Capacity in Spokane, WA Businesswire
15-Feb-2024 Areteia Therapeutics Announces Appointment of Daniel Becker, M.D., Ph.D. To Board of Directors Businesswire
15-Feb-2024 New Vitality Study Reveals: Employers Reduced Claims Costs by 4% and Achieved ROI of 180% from Claims Savings on Health and Wellbeing Program Businesswire
15-Feb-2024 SkyWater Signs Production Agreement with Nautilus Biotechnology to Fabricate Novel Biomedical Devices Businesswire
15-Feb-2024 Quince Therapeutics Appoints Former Reata Pharmaceuticals Chief R&D Officer Dr. Rajiv Patni to its Board of Directors Businesswire
15-Feb-2024 KalVista Pharmaceuticals Announces Pricing of a $160.1 Million Public Offering of Common Stock and Pre-Funded Warrants Businesswire
15-Feb-2024 Enalare Therapeutics Announces Publication of a Clinical Study Demonstrating the Effect of ENA-001 on Improving Propofol-Induced Depression of the Hypoxic Ventilatory Response Newswire
15-Feb-2024 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
15-Feb-2024 The Leading Digital Transformation Company Solita Is Expanding to Switzerland and Will Open a New Office in Zürich Businesswire
15-Feb-2024 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Thoughtworks Holding, Inc. (TWKS) on Behalf of Investors Businesswire
15-Feb-2024 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Amylyx Pharmaceuticals, Inc. (AMLX) on Behalf of Investors Businesswire
15-Feb-2024 Amylyx Pharmaceuticals, Inc. (AMLX) Stockholder Alert: Robbins LLP Reminds Stockholders of Amylyx Pharmaceuticals, Inc. Class Action Businesswire
15-Feb-2024 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of The Chemours Company (CC) on Behalf of Investors Businesswire
15-Feb-2024 KalVista Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants Businesswire
15-Feb-2024 GE HealthCare Management to Present at Upcoming Investor Conferences Businesswire
14-Feb-2024 Shareholder Alert: Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of Securities Class Action Lawsuit Against InMode Ltd. Businesswire
14-Feb-2024 HistoSonics Awarded Key Position in UK’s Novel Innovation Program Businesswire
14-Feb-2024 Sterilization Facilities Sued Over Puerto Rico Ethylene Oxide Emissions Businesswire